| Kettle_Partners Investment focus: emerging stage companies that enable telecommunications, new media and the Internet. |
| Kinetic_Ventures Investment focus: communications, Internet, and customer service companies. |
| Kuranda_Capital Focus: acquires and operates growth businesses in partnership with management focusing on manufacturing and value-added distribution businesses. |
| LF_Venture_Capital Provides grouth capital and global sourcing for consumer product companies. |
| Longworth_Venture_Partners Investment focus: early-stage companies involving e-commerce, Internet media, enterprise software and information technology services. |
| Lucent_Venture_Partners Focus: subsidiary of Lucent Technologies invests in early-stage technology companies in high-growth communications areas. |
| Marcus_&_Millichap_Venture_Partners Focus: early to late stage venture funding for real estate technology companies. |
| Marquette_Venture_Partners Investment focus: early-stage and emerging growth companies in consumer and business services, healthcare, and technology. |
| M/C_Venture_Partners Investment focus: early-stage communications and related information technology companies. |
| Meritage_Private_Equity_Fund Investment focus is on communications network and service opportunities. |
| Meritech_Capital_Partners Focus: pursues late-stage traditional growth companies as well as co-investments in corporate buy-outs and spin-offs of information technology companies. |
| Merlin_Biosciences Focus: broad-based venture capital and advisory company dedicated to the life sciences sector. |
| Mohr,_Davidow_Ventures Investment focus: early-stage companies with a strong information technology component. |
| Montreux_Equity_Partners Focus: invests primarily in early-stage technology and healthcare. |
| Nautic_Partners Focus: private equity firm specializing in the business services, healthcare, manufacturing, media and information, and telecommunications services industries. |
| New_Tech_Financing Focus: companies with revolutionary technology that is ready for commercialization. |
| New_World_Ventures Investment focus: early-stage technology and telecommunications companies. |
| Newbury_Ventures Equity capital firm specializes in communications and information technology industries. |
| newman_capital_group_-_private_equity_investment_firm Focus: investment capital for growth, acquisitions, recapitalizations and buyouts of manufactured homes, golf and leisure businesses. |
| Oak_Point_Partners Focus: Profitable companies with less than $15MM in revenues in niche markets. |
| Odyssey_Capital_Group Focus: equity investments in real estate, leveraged buy-outs and growth companies. |
| Onset_Ventures Investment focus: startups in information, communications and medical technologies. |
| ORESA_Ventures Investment focus: companies in the consumer goods, retailing and distribution, health care and pharmaceutical sectors in Central and Eastern Europe. |
| Osprey_Ventures Investment focus: early-stage and expansion-stage companies in the business and consumer technology marketplace. |
| Oxford_Bioscience_Partners Focus: equity financing and management assistance to start-up and early-stage companies in the bioscience and healthcare industries. |
| Pacesetter_Capital_Group Specializing in venture financing, leveraged buyouts, growth financing. Focus on broadcasting, technology infrastructure, and manufacturing and services. Features protfolio and links to resources. |
| PacRim_Venture_Partners Focus: investments in early-stage information technology companies in Silicon Valley. |
| Palomar_Ventures Focus: start-up and early-stage investments in information technology companies. |
| Polaris_Venture_Partners Investment focus: early-stage companies developing information and medical technology |
| Portico_Capital Focus: venture investment and advisory firm focused on the information services industry. |
| PRIMEDIA_Ventures Investment focus: early-stage Internet companies and other technology opportunities in such areas as commerce services, enterprise software applications, distance learning and advertising-related tech |
| Prism_Venture_Partners Focus: equity investments in start-up, early-stage and growth companies in the communications, Internet and healthcare industries. |
| Progeny_Ventures Investment focus: turn internal IT ventures and projects into independent start-up companies. |
| Providence_Equity_Partners Focus: equity investments in communications and media companies around the world. |
| Psilos Focus: financing to entrepreneurs in the healthcare and digital media industry. |
| Quaker_BioVentures Investment focus: life sciences. |
| Research_Corporation_Technologies Focus: identifies promising early-stage biomedical and optics technologies and provides seed funding and management support for critical early development work. |
| Rho_Management_Company,_Inc_ Investment focus: targets the Internet, healthcare and telecommunications industries. |
| Richland_Ventures Investment focus: expansion capital for service companies located primarily in the Southeast and Southwest |
| Ridgewood_Capital Investment focus: e-commerce, infrastructure technology, software, telecommunications/wireless and online media. |
We seek investments in Life Science companies in three principal areas: Drug Development, Medical Devices, and Healthcare Services. We consider business plans from experienced entrepreneurs passionately pursuing disruptive opportunities that fulfill large unmet medical or market needs.
Integra's strategy is to develop a portfolio of outstanding regional and national biomedical companies chosen within the framework of our partner's extensive biomedical, service and device expertise.
This will be executed through:
1. Classic venture investing in seed through A & B rounds.
2. Later stage and workout investing through Series C and D rounds of financing, growth equity investments and recapitalizations.
Collectively our partners have nearly a century of broad based life science experience in: basic scientific discovery, clinical care, medical device inventions, entrepreneurial start ups, and board leadership. Each of us has executive level start-up entrepreneurial experience.
We are value investors. As such, we have established a reputation for identifying unique situations where the market has not yet fully recognized the value inherent in a company's technology or IP. We have been successful in identifying such opportunities in large company spin-outs of non-core technology, in companies that have financed technology development through grant funding or other forms of non-dilutive equity, and in recapitalizations/ restructurings of venture backed companies.
Though we seek opportunities on a national basis, we focus our activities on the west coast, particularly in the Northwest. We prefer to invest as part of a syndicate, partnering with firms that also have technical or market expertise, capital depth, and/or strategic influence. We have led nearly one half of our deals in early-stage companies, as well as followed other funds in later-stage opportunities.
We are highly engaged in the growth and development of our portfolio companies. We recognize that technology is only as good as the people who manage it, and we look for a management team that has "been there, done that" and who share our commitment to excellence. We will partner with people who we respect, and who share our values. Their business must meet the needs of our complex health system and its constituents, with discipline and consistency, over a substantial period of time.
We view each of our investments as a partnership between our team, our co-investors, and company management. We will normally seek a board seat or an observer role.
We seek to work with entrepreneurs who are not looking for a quick infusion of cash but who welcome the active support, expertise and enthusiasm that we bring to our portfolio companies, and who appreciate our commitment to our investors.
Prescription Drugs
for Half the Price: Wellpartner Smooths Way for Clinics to Buy Them
November 5, 2008
Targeted Growth
Sees Future In Your Breakfast Bowl
September 11, 2008
Wellpartner
Looks To Grow With $16M Series D
August 5, 2008
MediQuest
Vying to Get First Drug Across FDA Goal Line, Put Raynaud’s in Your Vocabulary
July 15, 2008
Blue
Heron Strives to Replace Gene-Making Grunt Work with Custom Manufacturing
June 18, 2008
Tepha
Announces First Human Usage of Medical Devices Derived from New
Class of Resorbable Polymers
April 17, 2008
Millipore, Guava
to Integrate Flow Cytometry Reagents, Instrumentation
March 04, 2008
Higher crop yields, more biofuel
November 19, 2007
Patent Awarded to MediQuest
Therapeutics
October 29, 2007
Integra portfolio company
Blue Heron Biotechnology featured in NYT Article
September 12, 2007
see more news
